1. The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring;Bracht;Curr. Oncol. Rep.,2020
2. Correction to: The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring;Bracht;Curr. Oncol. Rep.,2020
3. Highly Sensitive Detection of the Immune Checkpoint PD-L1-Positive Circulating Tumor Cells Based on Steric Hindrance;Gong;Anal. Chem.,2022
4. Liquid biopsy and minimal residual disease - latest advances and implications for cure, Nature reviews;Pantel;Clin. Oncol.,2019
5. Surgical Drain Fluid as a Novel Liquid Biopsy Analyte to Measure Postoperative Minimal Residual Disease in HPV+ Oropharyngeal Cancer;Ramirez;Int. J. Radiat. Oncol. Biol. Phys.,2021